• Molecular NameTubocurarine
  • SynonymD-Tubocurarine; D-Tubocurarine Chloride; Isoquinoline Alkaloid; Tubocurarin; Tubocurarine Chloride; Tubocurarinum
  • Weight609.743
  • Drugbank_IDDB01199
  • ACS_NO57-95-4
  • Show 3D model
  • LogP (experiment)N/A
  • LogP (predicted, AB/LogP v2.0)1.14
  • pkaN/A
  • LogD (pH=7, predicted)0.36
  • Solubility (experiment)N/A
  • LogS (predicted, ACD/Labs)(ph=7)-0.56
  • LogSw (predicted, AB/LogsW2.0)3.97
  • Sw (mg/ml) (predicted, ACD/Labs)58.95
  • No.of HBond Donors2
  • No.of HBond Acceptors8
  • No.of Rotatable Bonds2
  • TPSA80.62
  • StatusFDA approved
  • AdministrationIV
  • PharmacologyIt is an antagonist of nicotinic neuromuscular acetylcholine receptors that is used to paralyse patients undergoing anaesthesia.
  • Absorption_value0.0
  • Absorption (description)N/A
  • Caco_2N/A
  • BioavailabilityN/A
  • Protein binding41.5
  • Volume of distribution (VD)0.3 to 0.6 L/kg
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmN/A
  • Half life2~4 h
  • ExcretionN/A
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicityN/A
  • LD50 (rat)N/A
  • LD50 (mouse)N/A